Download presentation
Presentation is loading. Please wait.
1
Volume 24, Issue 11, Pages 1888-1889 (November 2016)
Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach Jacques P Tremblay, Jean-Paul Iyombe-Engembe, Benjamin Duchêne, Dominique L Ouellet Molecular Therapy Volume 24, Issue 11, Pages (November 2016) DOI: /mt Copyright © 2016 American Society of Gene & Cell Therapy Terms and Conditions
2
Figure 1 A hybrid spectrin-like repeat formed by cutting in exons 50 and 54 with the CRISPR/Cas9 technique. Molecular Therapy , DOI: ( /mt ) Copyright © 2016 American Society of Gene & Cell Therapy Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.